Header Logo

Connection

Jacek Skarbinski to Atherosclerosis

This is a "connection" page, showing publications Jacek Skarbinski has written about Atherosclerosis.
Connection Strength

0.178
  1. Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE). Am Heart J. 2021 05; 235:54-64.
    View in: PubMed
    Score: 0.178

© 2024 Kaiser Permanente